CLPTClearPoint Neuro, Inc.
$9.13-62% 1Y
$9.13
$8.6652 weeks$26.98
Is the price fair?
What CLPT's price assumes
ClearPoint Neuro, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 12.7× revenue.
12.7
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 49.9
Price / book · as of 2026-Q2
- EV / sales
- 13.2
EV / sales
Details›
- Price / bookas of 2026-Q2
- 49.9
- EV / EBIToperating margin −73%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q2
- 13.2
- Market capitalisation30.5 million shares, counted Jul 27, 2026
- $279M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.